Paper36757367
Targeting the gut-microbiota-brain axis in irritable bowel disease to improve cognitive function - recent knowledge and emerging therapeutic opportunities.
Tang H and 5 others. Rev Neurosci, 2023. Cited by 10 papers, by iCite.
Cite this record
ConductScience Library. Targeting the gut-microbiota-brain axis in irritable bowel disease to improve cognitive function - recent knowledge and emerging therapeutic opportunities. Papers, record 36757367. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36757367
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Targeting the gut-microbiota-brain axis in irritable bowel disease to improve cognitive function - recent knowledge and emerging therapeutic opportunities.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Irritable Bowel Syndrome | Major topic |
| Autism Spectrum Disorder | Major topic |
| Microbiota | Major topic |
| Inflammatory Bowel Diseases | Major topic |
| Humans | |
| Brain-Gut Axis | |
| Brain | |
| Cognition |
Source PubMed
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40697271 | Changes in white matter microstructure in the brain of patients with inflammatory bowel disease are associated with abdominal pain. | Front Neurosci | 2025 | https://conductscience.org/library/papers/40697271 | PubMed |
| 40658164 | Gut microbiota in anxiety and depression: mechanisms, drug interactions, and therapeutic implications. | Pharmacol Rep | 2025 | https://conductscience.org/library/papers/40658164 | PubMed |
| 40091637 | Neuroinflammation in Adaptive Immunodeficient Mice with Colitis-like Symptoms. | Exp Neurobiol | 2025 | https://conductscience.org/library/papers/40091637 | PubMed |
| 38872954 | Enteric Nervous System Alterations in Inflammatory Bowel Disease: Perspectives and Implications. | Gastrointest Disord (Basel) | 2024 | https://conductscience.org/library/papers/38872954 | PubMed |
| 38076462 | Intestinal flora study reveals the mechanism of Danggui Shaoyao San and its decomposed recipes to improve cognitive dysfunction in the rat model of Alzheimer's disease. | Front Cell Infect Microbiol | 2023 | https://conductscience.org/library/papers/38076462 | PubMed |
| 37248586 | [Prevalence Survey of Functional Dyspepsia and Irritable Bowel Syndrome in Chinese College Students Based on Rome Ⅳ Diagnostic Criteria]. | Sichuan Da Xue Xue Bao Yi Xue Ban | 2023 | https://conductscience.org/library/papers/37248586 | PubMed |
| 36836185 | Role of Gut Microbiota in Neurological Disorders and Its Therapeutic Significance. | J Clin Med | 2023 | https://conductscience.org/library/papers/36836185 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36757367
GET https://conductscience.org/api/papers/v1/36757367/authors